Contract biopharma plant opens in Finland
In an unusual move, Finnish science park Medipolis has set up a new Good Manufacturing Practice (GMP) pilot plant to take advantage of the growing demand for biopharmaceutical production capacity.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs